Immunohistochemical analyses of tumor sections from patients with KRAS-mutant NSCLC showed correlations between BACH1 and VEGFA and BACH1 and VEGFR2 (Figure 6, B and C, and Supplemental Table 2). This evidence concerns the gene VEGFA and neoplasm.